PA500425: Managing polypharmacy and multimorbidity
[Page last updated: 05 August 2021]
| Academic Year: | 2021/2 |
| Owning Department/School: | Department of Pharmacy & Pharmacology |
| Credits: | 15 CATS credits |
| Notional Study Hours: | 150 |
| Level: | FHEQ level 7 |
| Period: |
|
| Assessment Summary: | CW80EX20 |
 Assessment Detail: |
|
| Supplementary Assessment: |
|
| Requisites: | |
| Aims: | To update knowledge on polypharmacy and multimorbidity and reduce associated risks such as adverse drug reactions.� �
To appraise the tools available to manage polypharmacy to reduce risk and adverse outcomes such as avoidable hospital admissions.� � Develop consultation skills to consider the ethical challenges of de-prescribing.� � To enable pharmacists to apply medicines� optimisation� to support patients on multiple medicines.� |
| Learning Outcomes: | * Explain the different types of adverse drug reactions and drug interactions and apply this knowledge to� minimise� risks associated with polypharmacy.� * Discuss the co-morbidities, patient factors and drugs likely to increase the risk of adverse drug reactions and how to� minimise� these risks through appropriate monitoring or review.� * Critically evaluate the currently available screening tools and resources for managing the risks associated with polypharmacy.� * Demonstrate a systematic approach to medication reviews of patients with multiple co-morbidities and polypharmacy.� * Demonstrate good communication and patient� centred� consultation skills to approach the ethical decisions regarding de-prescribing, engaging the patient in shared decision-making about their health.� * Identify times of high risk in patient care and apply clinical reasoning,� professional judgement� and leadership� within� the� multidisciplinary� team� to improve patient� outcomes. |
| Skills: | Study skills�
Basic clinical examination skills� Consultation skills� Communication skills� Written communication� Problem solving� Working with others� Handling information� Leadership skills - influencing skills, challenging inappropriate prescribing� Planning and� organisation� Improving learning and performance� Scientific and practical skills� Reflective practice� Information & communication technology |
| Content: | * Defining polypharmacy and multimorbidity� * Adverse drug reactions and interactions� * Reducing hospital admissions� * Identification of high risk patients and high risk drugs - multiple co-morbidities� * Falls risk� * Tools for managing polypharmacy� * De-prescribing - difficult discussions and ethical decisions� � * Transfer of Care - a high risk time� * Pharmacy services to support medicines� optimisation� in polypharmacy - medicines review and medicines reconciliation� * Evidence-based polypharmacy� * Managing care home medicines� optimisation� * Communication challenges� * Care plans. |
| Programme availability: |
PA500425 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|